Avalo Therapeutics (AVTX) Long-Term Debt Repayments (2015 - 2019)

Avalo Therapeutics (AVTX) has 4 years of Long-Term Debt Repayments data on file, last reported at $183114.0 in Q4 2019.

• Quarterly Long-Term Debt Repayments changed N/A year-over-year to $183114.0 in Q4 2019, while the trailing twelve-month figure through Sep 2020 was $183114.0 (up 150.75% YoY) and the FY2019 annual result came in at $256140.0, changed N/A from the prior year.
• Long-Term Debt Repayments grew to $183114.0 in Q4 2019, from $24342.0 in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $892721.0 in Q2 2017 to a low of $24342.0 in Q1 2019.
• A 4-year average of $577169.7 and a median of $787946.0 in 2015 frame the typical range for Long-Term Debt Repayments.
• The widest YoY moves for Long-Term Debt Repayments: up 8.99% in 2017, down 27.48% in 2017.
• Tracing AVTX's Long-Term Debt Repayments over 4 years: stood at $787946.0 in 2015, then climbed by 8.48% to $854732.0 in 2016, then slipped by 29.03% to $606610.0 in 2017, then sank by 69.81% to $183114.0 in 2019.
• The last three Long-Term Debt Repayments figures came in at $183114.0 (Q4 2019), $24342.0 (Q3 2019), and $24342.0 (Q2 2019), per Business Quant data.